(19)
(11) EP 0 904 109 A1

(12)

(43) Date of publication:
31.03.1999 Bulletin 1999/13

(21) Application number: 97915001.0

(22) Date of filing: 12.03.1997
(51) International Patent Classification (IPC): 
A61K 9/ 127( . )
A61K 47/ 32( . )
A61K 47/ 42( . )
C07K 14/ 705( . )
A61K 31/ 704( . )
A61K 47/ 36( . )
A61K 47/ 48( . )
C07K 16/ 28( . )
(86) International application number:
PCT/US1997/003832
(87) International publication number:
WO 1997/033618 (18.09.1997 Gazette 1997/40)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 15.03.1996 US 19960616693

(71) Applicants:
  • THERATECH, INC.
    Salt Lake City Utah 84108 (US)
  • THE UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Salt Lake City, Utah 84108 (US)

(72) Inventors:
  • PRAKASH, Ramesh, K.
    Salt Lake City, UT 84121 (US)
  • KOPECEK, Jindrich
    Salt Lake City, UT 84108 (US)
  • KOPECKOVA, Pavla
    Salt Lake City, UT 84108 (US)
  • OMELYANENKO, Vladimir
    Sandy, UT 84093 (US)

(74) Representative: Thomson, Paul Anthony 
Potts, Kerr & Co. 15, Hamilton Square
Birkenhead Merseyside L41 6BR
Birkenhead Merseyside L41 6BR (GB)

   


(54) TARGETING MACROMOLECULAR PRODRUGS TO T LYMPHOCYTES